The HeartPad is not for sale inside or outside the United States. It is intended for open or minimally invasive ablation procedures and is positioned adjacent to the heart using direct vision, video guidance, or cardiac mapping.
Pasquale Santangeli and J. Peter Weiss serve on the Scientific Advisory Board. Santangeli is associated with Cleveland Clinic Foundation Hospitals, and Weiss is associated with the University of Arizona School of Medicine and Banner University of Arizona Medical Center.
Corfigo aims to repair hearts that are not working properly using creativity and technology. Its name combines “cor,” meaning heart, and “figo,” meaning fix or repair in Latin.
The HeartPad “XLT” (Extremely Low Temperature) Cryoablation System is intended to ablate cardiac tissue from the heart’s outer surface while protecting adjacent structures from unintentional ablation injury. It is designed for open and minimally invasive surgical procedures.